Skip to content

Press Releases

Public Relations: Andrew Noble

March 18, 2024
New

DNAnexus to Showcase the Power of High-Value Multi-Omics Data at the Precision Medicine in IBD Summit

Co-founder of Ovation to share how researchers are using DNAnexus’ Precision Health Data Cloud to streamline analysis, identify optimal therapeutic targets, and advance drug discovery.

Read More
February 21, 2024

DNAnexus and Curio Bioscience Announce Collaboration to Streamline and Simplify Data Analysis for Large-Scale Spatial Transcriptomics Projects

Combination of Curio Seeker with Precision Health Data Cloud provides scientists with a secure and scalable solution for managing and sharing high-resolution, spatially resolved gene expression data.

Read More
February 12, 2024

DNAnexus and LORENZ Partner to Enable Collaborative Regulatory Submission Validation and Scientific Review in the Cloud via Trusted Regulatory Spaces

Companies have joined with industry leaders and FDA on Project PRISM to advance solutions that can improve the submission, review and ease of communication for human drug and biologics applications.

Read More
February 06, 2024

Element Biosciences and DNAnexus® Announce Collaboration to Advance Multi-Omics Analysis

Direct integration allows customers to stream data from Element’s AVITI™ System directly to DNAnexus.

Read More
January 23, 2024

DNAnexus and TMA Precision Health Join Forces to Improve Diagnostics and Treatment Options for Rare Diseases

Trusted research environment provides secure access to high-quality, de-identified whole genome sequencing data and associated medical records.

Read More

News

December 06, 2023
New

World’s largest genetic project opens the door to new era for treatments and cures: UK Biobank’s major milestone

In a momentous landmark for medical research, UK Biobank has today unveiled incredible new data from whole genome sequencing of its half a million participants. This is set to drive the discovery of new diagnostics, treatments and cures and, uniquely, is available to approved researchers worldwide, via a protected database containing only de-identified data (e.g. name, address, date of birth, name of GP and more stripped out).

Read More
March 07, 2023

DNAnexus included in Fast Company's 10 most innovative biotech companies of 2023

Among the 2023 Most Innovative Companies in Biotech, Fast Company is recognizing breakthroughs in DNA sequencing and spatial transcriptomics, along with innovations in biological-specimen sourcing, cell-separation technology, and the production of synthetic antibodies. 

Read More
March 18, 2022

Blackstone Growth Leads $200 Million Investment in DNAnexus

DNAnexus, founded in 2010, has a platform that puts massive sets of genomic data into the cloud so they can be accessed and analyzed by researchers who may be unable to process that volume onsite.
Read More